Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
1 Not yet recruiting Acupuncture and Moxibustion for Hyperlipemia
Condition: Hyperlipidemias
Interventions: Other: acupuncture and moxibustion;   Drug: Simvastatin;   Other: Therapeutic Lifestyle Change
2 Recruiting Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Condition: Hyperlipidemia
Intervention: Drug: TAK-085
3 Recruiting A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
4 Recruiting Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Condition: Hyperlipidemias
Interventions: Drug: Antroquinonol;   Drug: placebo
5 Recruiting A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia
Condition: Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Other: Placebo
6 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
7 Recruiting Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Atorvastatin 20 mg;   Drug: Cholestyramine 8 g;   Drug: Omega-3 2g;   Drug: Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg;   Behavioral: Lifestyle modification
8 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
9 Not yet recruiting Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Condition: Hyperlipidemia
Interventions: Drug: TAK-085;   Other: Not treated with omega-3-acid ethyl esters
10 Recruiting Effect of Butter & MCT Oil on Lipoproteins - A RCT
Condition: Hyperlipidemia
Intervention: Dietary Supplement: MCT oil + Butter in Coffee
11 Recruiting Acute Microvascular Changes With LDL Apheresis
Condition: Hyperlipidemia
Intervention: Procedure: Plasmapharesis
12 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
13 Recruiting Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
Condition: Hyperlipidemias
Interventions: Drug: HCP1105;   Drug: HGP0816;   Drug: Placebo of HCP1105;   Drug: Placebo of HGP0816
14 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
15 Recruiting Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Condition: Hyperlipidemia
Intervention: Drug: Atorvastatin
16 Not yet recruiting A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
Condition: Hyperlipidemias
Intervention:
17 Recruiting Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia
Condition: Oxidative Stress
Interventions: Dietary Supplement: XXS;   Dietary Supplement: non-XXS
18 Recruiting Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflamation Study in Patients With Elevated Lipoprotein(a) (Lp(a)).
Condition: Subjects With Hyperlipidemia, Dyslipidemia
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
19 Recruiting Chart Review of Repatha® in Subjects With Hyperlipidaemia
Condition: Hypercholesterolaemia
Intervention:
20 Recruiting The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Conditions: Diabetes;   Hyperlipidemia
Interventions: Drug: Metformin + Rosuvastatin;   Drug: JLP-1310

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.